Jaguar Animal Health
高管
查看带有其 16 名主要高管的组织结构图
Jaguar Animal Health 搜索最多的简介
- Lisa Conte, Chief Executive Officer, Executive Director
- John Micek, Director
- James Bochnowski, Chairman of the Board
高管在Jaguar Animal Health变化
- Massimo Radaelli已作为President of International加入公司 (新闻发布的2024四月3号).
创建提醒
跟踪 Jaguar Animal Health 的高管变动
药店
Jaguar Animal Health 拥有 1,865 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Jaguar Animal Health 的最新新闻稿
- Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
- Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
- Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
- Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
- Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
- Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
- Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
- Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
- Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
- Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
- View more press releases Close
通过电子邮件
